UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL people

Group by: Type | Date
Jump to: Article | Thesis
Number of items: 18.

Article

Di Donfrancesco, A; Berlingieri, C; Giacomello, M; Frascarelli, C; Magalhaes Rebelo, AP; Bindoff, LA; Reeval, S; ... Brunetti, D; + view all (2023) PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients. Frontiers in Pharmacology , 14 , Article 1220620. 10.3389/fphar.2023.1220620. Green open access
file

Di Donfrancesco, Alessia; Massaro, Giulia; Di Meo, Ivano; Tiranti, Valeria; Bottani, Emanuela; Brunetti, Dario; (2022) Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective. Pharmaceutics , 14 (6) , Article 1287. 10.3390/pharmaceutics14061287. Green open access
file

Geard, AF; Massaro, G; Hughes, MP; Arbuthnot, P; Waddington, SN; Rahim, AA; (2025) Generation and Treatment of a Novel Severe Model of Visceral Gaucher Disease by Genetic Therapy. Pharmaceutics , 17 (5) , Article 650. 10.3390/pharmaceutics17050650. Green open access
file

Holthaus, S-MK; Herranz-Martin, S; Massaro, G; Aristorena, M; Hoke, J; Hughes, MP; Maswood, R; ... Ali, RR; + view all (2019) Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease. Human Molecular Genetics , 28 (23) pp. 3867-3879. 10.1093/hmg/ddz210. Green open access
file

Howe, Geoffrey; Bal, Mehtap; Wasmuth, Matthew; Massaro, G; Rahim, Ahad; Ali, Sadfer; Rivera, Milena; ... Nesbeth, Darren; + view all (2024) An autonucleolytic suspension HEK293F host cell line for high-titre serum-free AAV5 and AAV9 production with reduced levels of DNA impurity. Molecular Therapy - Methods and Clinical Development , Article 101317. 10.1016/j.omtm.2024.101317. (In press). Green open access
file

Hughes, Michael Paul; Nelvagal, Hemanth Ramesh; Coombe-Tennant, Oliver; Smith, Dave; Smith, Claire; Massaro, Giulia; Poupon-Bejuit, Laura; ... Rahim, Ahad Abdul; + view all (2023) A Novel Small NPC1 Promoter Enhances AAV-Mediated Gene Therapy in Mouse Models of Niemann–Pick Type C1 Disease. Cells , 12 (12) , Article 1619. 10.3390/cells12121619. Green open access
file

Hughes, MP; Smith, DA; Morris, L; Fletcher, C; Colaco, A; Huebecker, M; Tordo, J; ... Rahim, AA; + view all (2018) AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease. Human Molecular Genetics , 27 (17) pp. 3079-3098. 10.1093/hmg/ddy212. Green open access
file

Karda, R; Buckley, SM; Mattar, CN; Ng, J; Massaro, G; Hughes, MP; Kurian, MA; ... Rahim, AA; + view all (2014) Perinatal systemic gene delivery using adeno-associated viral vectors. Front Mol Neurosci , 7 , Article 89. 10.3389/fnmol.2014.00089. Green open access
file

Massaro, Giulia; Geard, Amy F; Nelvagal, Hemanth R; Gore, Katrina; Clemo, Nadine K; Waddington, Simon N; Rahim, Ahad A; (2024) Comparison of different promoters to improve AAV vector-mediated gene therapy for neuronopathic Gaucher disease. Human Molecular Genetics , Article ddae081. 10.1093/hmg/ddae081. (In press). Green open access
file

Massaro, G; Geard, AF; Liu, W; Coombe-Tennant, O; Waddington, SN; Baruteau, J; Gissen, P; (2021) Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development. Biomolecules , 11 (4) , Article 611. 10.3390/biom11040611. Green open access
file

Massaro, G; Hughes, MP; Whaler, SM; Wallom, K-L; Priestman, DA; Platt, FM; Waddington, SN; (2020) Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes. Human Molecular Genetics 10.1093/hmg/ddz317. (In press). Green open access
file

Massaro, G; Mattar, CNZ; Wong, AMS; Sirka, E; Buckley, SMK; Herbert, BR; Karlsson, S; ... Rahim, AA; + view all (2018) Fetal gene therapy for neurodegenerative disease of infants. Nature Medicine , 24 pp. 1317-1323. 10.1038/s41591-018-0106-7. Green open access
file

Plotegher, N; Perocheau, D; Ferrazza, R; Massaro, G; Bhosale, G; Zambon, F; Rahim, AA; ... Duchen, MR; + view all (2020) Impaired cellular bioenergetics caused by GBA1 depletion sensitizes neurons to calcium overload. Cell Death & Differentiation , 27 pp. 1588-1603. 10.1038/s41418-019-0442-2. Green open access
file

Poupon-Bejuit, L; Hughes, MP; Liu, W; Geard, A; Faour-Slika, N; Whaler, S; Massaro, G; (2022) A GLP1 receptor agonist diabetes drug ameliorates neurodegeneration in a mouse model of infantile neurometabolic disease. Scientific Reports , 12 (1) , Article 13825. 10.1038/s41598-022-17338-1. Green open access
file

Snowball, A; Chabrol, E; Wykes, RC; Shekh-Ahmad, T; Cornford, JH; Lieb, A; Hughes, MP; ... Schorge, S; + view all (2019) Epilepsy Gene Therapy Using an Engineered Potassium Channel. Journal of Neuroscience , 39 (16) pp. 3159-3169. 10.1523/JNEUROSCI.1143-18.2019. Green open access
file

Vardi, A; Zigdon, H; Meshcheriakova, A; Klein, AD; Yaacobi, C; Eilam, R; Kenwood, BM; ... Futerman, AH; + view all (2016) Delineating pathological pathways in a chemically-induced mouse model of Gaucher disease. The Journal of Pathology , 239 (4) pp. 496-509. 10.1002/path.4751. Green open access
file

Zwi-Dantsis, Limor; Mohamed, Saira; Massaro, Giulia; Moeendarbary, Emad; (2025) Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy. Viruses , 17 (2) , Article 239. 10.3390/v17020239. Green open access
file

Thesis

Massaro, Giulia; (2018) Intravenously administered gene therapy for neuronopathic Gaucher disease. Doctoral thesis (Ph.D), UCL (University College London). Green open access
file

This list was generated on Sun Feb 8 02:07:18 2026 GMT.